The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus

被引：0
|
作者：
Xueyang Zhang
Ran Bai
Yong Jia
Junwei Zong
Yongbo Wang
Yanan Dong
机构：
[1] The first affiliated Hospital of Dalian Medical University,Department of Endocrinology
[2] Dalian,Institute of Integrative Medicine
[3] Liaoning,Department of Orthopedics
[4] Dalian Medical University,undefined
[5] The first affiliated Hospital of Dalian Medical University,undefined
[6] Dalian,undefined
[7] Liaoning,undefined
来源：
International Journal of Diabetes in Developing Countries | 2020年 / 40卷
关键词：
Liraglutide; Nonalcoholic fatty liver disease; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：491 / 499
页数：8
相关论文
共 50 条
  • [41] Role of Canagliflozin in the Evolution of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Tejera-Perez, Cristina
    Sanchez-Bao, Ana
    Soto-Gonzalez, Alfonso
    Bellido-Guerrero, Diego
    DIABETES, 2017, 66 : A346 - A346
  • [42] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus in Post-menopausal women
    Sud, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [43] Efficacy and Safety of Sitagliptin for the Treatment of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus
    Fukuhara, Takayuki
    Hyogo, Hideyuki
    Ochi, Hidenori
    Fujino, Hatsue
    Kan, Hiromi
    Naeshiro, Noriaki
    Honda, Yohji
    Miyaki, Daisuke
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Chayama, Kazuaki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (130) : 323 - 328
  • [44] Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
    Mantovani, Alessandro
    Targher, Giovanni
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (13)
  • [45] Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
    Younossi, Zobair M.
    Gramlich, Terry
    Matteoni, Christi A.
    Boparai, Navdeep
    Mccullough, Arthur J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (03) : 262 - 265
  • [46] Antifibrotic Effect of Combination Dapagliflozin and Metformin Therapy in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Lavrynenko, Olga
    Kravchun, Nonna
    Zemlianitsyna, Olha
    Dunaeva, Inna
    Defronzo, Ralph A.
    Cersosimo, Eugenio
    Karachentsev, Iuriy
    DIABETES, 2019, 68
  • [47] The effect of ertugliflozin in patients with nonalcoholic fatty liver disease associated with type 2 diabetes mellitus: A randomized controlled trial
    Khaliq, Adil
    Badshah, Haroon
    Shah, Yasar
    Rehman, Inayat Ur
    Khan, Kashif Ullah
    Ming, Long Chiau
    Cheng, Maong Hui
    MEDICINE, 2024, 103 (45)
  • [48] The Effect of Lixisenatide and Dapagliflozin in Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus Compared with Sitagliptin and Pioglitazone
    Koutsovasilis, Anastasios
    Sotiropoulos, Alexios
    Pappa, Maria
    Papadaki, Despina
    Kordinas, Vasilis
    Tamvakos, Charalampos
    Bourikou, Maria
    Bousboulas, Stavros
    Peppas, Theodoros
    DIABETES, 2018, 67
  • [49] NONALCOHOLIC FATTY LIVER DISEASE Liver disease: an overlooked complication of diabetes mellitus
    Arrese, Marco
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (12) : 660 - 661
  • [50] Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease
    Lin, X.
    Zhang, Z.
    Chen, J. M.
    Xu, Y. Y.
    Ye, H. R.
    Cui, J.
    Fang, Y.
    Jin, Y.
    Zhu, D. R.
    Yuan, L.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 2940 - 2946
12345